Document:

832012Form8-kJRCTerminationAgt

Exhibit 10.17.14

TERMINATION OF
AMENDED AND RESTATED EMPLOYMENT AGREEMENT, AS AMENDED

THIS TERMINATION OF AMENDED AND RESTATED EMPLOYMENT AGREEMENT, AS AMENDED (the “Termination”), is made and entered into this 31st day of July, 2012, to be effective as of August 3, 2012, by and between OLD DOMINION FREIGHT LINE, INC. (the “Company”), a corporation organized and existing under the laws of the Commonwealth of Virginia and having its principal office at Thomasville, North Carolina, and John R. Congdon (the “Employee”), an individual residing at Richmond, Virginia.

RECITALS:

WHEREAS, the Company and the Employee entered into an Amended and Restated Employment Agreement, effective June 1, 2008 and scheduled to expire on May 31, 2010, which was extended to May 21, 2012 by the First Amendment to Amended and Restated Employment Agreement and further extended to May 31, 2014 pursuant to the Second Amendment to Amended and Restated Employment Agreement (together, the “Agreement”); and

WHEREAS, pursuant to Section 5.2 of the Agreement, the Employee desires to terminate the Agreement effective August 3, 2012.

AGREEMENT:

NOW, THEREFORE, the Company and the Employee hereby agree as follows:

		
	1.
	The Agreement shall be terminated and shall be of no further force or effect as of August 3, 2012.

		
	2.
	 The Company and the Employee waive the requirement for one hundred and twenty (120) days written notice in order to terminate the Agreement.

		
	3.
	The Employee understands and agrees that termination of the Agreement shall not cause the Company to incur any penalty or obligation whatsoever and shall not be subject to ARTICLE 10, ARTICLE 29 or any other ARTICLE, covenant, condition, or limitation contained in or incorporated by reference into the Agreement.  

		
	4.
	Neither the Company nor the Employee shall have any further responsibilities or expectations with respect to the Agreement, and further employment of the Employee by the Company after August 3, 2012, if any, shall be on an “at-will” basis and such employment may be terminated by the Company or the Employee at any time with or without notice, and with or without cause.

		
	5.
	If the Employee subsequently obtains employment with the Company in accordance with Paragraph 4, above, the following life insurance policies currently owned by the Company (collectively, the “Policies”) on the life of the Employee shall be maintained subject to the terms outlined below: 

	
			
	

	 
	 

	Issuer
	 
	Policy No.

	 
	 
	 

	The Northwestern Mutual Life
	 
	6204845 (“Policy No. 1”)

	Insurance Company 

	 
	 

	The Northwestern Mutual Life
	 
	7040586 (“Policy No. 2”)

	Insurance Company
	 
	 

The Employee was previously granted the right to designate the beneficiary of $500,000 of the death benefit payable under Policy No. 1 and $1,500,000 of the death benefit payable under Policy No. 2 (the “Designation Rights”).  The Company shall maintain the Policies in full force and effect and pay all premiums required to be paid under such Policies, if any, during any period of the Employee’s employment.  Upon the termination of the Employee’s employment for any reason other than death (the “Termination Date”), the Designation Rights shall cease as of the Termination Date and the Employee shall not have any rights under or in the Policies.  Following the Employee’s Termination Date, the Company alone may exercise all rights under the Policies.  The Employee shall take all actions and execute any and all documents as may be necessary or required to relinquish the Designation Rights as of the Termination Date.

IN WITNESS WHEREOF, the parties have executed this Termination on the day and year first above written.

EMPLOYEE

/s/ John R. Congdon            
John R. Congdon

OLD DOMINION FREIGHT LINE, INC.

By: /s/ David S. Congdon        
       David S. Congdon
       President and Chief Executive Officer

Attest:

/s/ Ross H. Parr           
Ross H. Parr
SecretaryAMLN Exhibit 10.1 2012.6.30

Exhibit 10.1
CONFIDENTIAL
*** Text Omitted and Filed Separately 
with the Securities and Exchange Commission.
Confidential Treatment Requested Under 17 C.F.R Sections 200.80(b)(4)
and Rule 406 of the Securities Act of 1933, as amended.

AMENDMENT TO 
COMMERCIAL SUPPLY AGREEMENT

This AMENDMENT TO COMMERCIAL SUPPLY AGREEMENT (the “Amendment”) is entered into as of April 17, 2012 (the “Amendment Effective Date”) by and between Amylin Pharmaceuticals, Inc. (“AMYLIN”), having a principal place of business at 9360 Towne Centre Drive, San Diego, CA 92121, and Bachem Americas, Inc. (“BACHEM”), having its principal place of business at 3132 Kashiwa Street, Torrance, CA 90505. 
WHEREAS, AMYLIN and BACHEM are Parties to that certain Commercial Supply Agreement, effective June 21, 2005 as amended on March 8, 2006 and November 20, 2008 (the “Agreement”);
WHEREAS, Bachem, Inc. on March 5, 2012 merged with Bachem Americas, Inc.  and where said merger does not in manner alter or affect the performance of BACHEM  under this Agreement, and where Bachem Americas, Inc. is made a party to this Agreement and is also responsible for the performance and obligations under the Agreement; and
WHEREAS, AMYLIN and BACHEM wish to amend the Agreement in the manner set forth herein.
NOW, THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein, the parties agree as follows:
		
	1.
	The Parties agree that all capitalized terms used but not otherwise defined herein shall have the meanings given such terms in the Agreement. 

		
	2.
	The Parties agree that Bachem Americas, Inc. shall be added to the Agreement, and all references to BACHEM shall include both Bachem, Inc. and Bachem Americas, Inc.

3.    The Parties agree to add Section 3.15 Insurance and Storage of Product.
Add Section 3.15 as follows:  Insurance and Storage of Product.  AMYLIN is responsible for maintaining insurance for the Product stock held on the premises at BACHEM which has been    

1.
ID 25743

CONFIDENTIAL

invoiced to AMYLIN, but is held in storage at BACHEM according to AMYLIN’s request. BACHEM will maintain the Product in a clean, secured, segregated area at its facility and will store the Product in compliance with GMP requirements and in a manner consistent with maximizing the shelf life of the Product stock which shall remain clean, properly packaged and free of contamination.  BACHEM shall the store the Product for a maximum period of [...***...] ([...***...]) [...***...] from the Effective Date of this Amendment, unless otherwise agreed to by the Parties in writing. 
4.     The Parties agree to add Section 3.16 Payment for Storage of Product.
Add Section 3.15 as follows:  Payment for Storage of Product.  BACHEM will invoice AMYLIN on an [...***...] basis for the Storage of the Product commencing upon execution of the Amendment.  Storage fees shall be in the amount of $[...***...] for the [...***...] and $[...***...] for [...***...] to be held in storage.  Storage fees shall be assessed and invoiced on [...***...] of [...***...] and shall apply for the [...***...] or any [...***...].  For clarity, BACHEM shall not refund storage fees on a pro-rated basis.  Storage fees for the [...***...] shall be assessed and invoiced promptly upon execution of this Amendment.  Thereafter, AMYLIN will pay BACHEM within [...***...] ([...***...]) days of the invoice date.  
Entire Agreement.  The Agreement, as amended by this Amendment, sets forth the entire agreement between AMYLIN and BACHEM with respect to its subject matter, and fully supersedes any and all prior and contemporaneous agreements or understandings pertaining to the subject matter of the Agreement, as amended by this Amendment.  Except as specifically amended by this Amendment, the terms and conditions of the Agreement shall remain in full force and effect. 
5.    Counterparts; Facsimile.  This Amendment may be executed in any number of separate counterparts, each of which shall be deemed to be an original, but which together shall constitute one and the same instrument.  This Amendment may be executed by facsimile or PDF signatures, which signatures shall have the same force and effect as original signatures. 
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

***CONFIDENTIAL TREATMENT REQUESTED
2.
ID 25743

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly authorized representatives.

BACHEM AMERICAS, INC.        AMYLIN PHARMACEUTICALS, INC.
By: /s/ Alex Fässler        By: /s/ Paul Marshall    
Name:  Alex Fässler        Name: Paul Marshall    
Title: President & COO        Title: Sr. Vice President, Operations    
Date: April 19, 2012_____________        Date: 27 April 2012______________

ID 25743AMLN Exhibit 10.2 2012.6.30

Exhibit 10.2
*** Text Omitted and Filed Separately 
with the Securities and Exchange Commission.
Confidential Treatment Requested Under 17 C.F.R Sections 200.80(b)(4)
and Rule 406 of the Securities Act of 1933, as amended.

SIXTH AMENDMENT TO EXENATIDE MANUFACTURING AGREEMENT
THIS SIXTH AMENDMENT to the Exenatide Manufacturing Agreement (the “Sixth Amendment”) originally made and entered into as of October 1, 2003, by and between Amylin Pharmaceuticals, Inc. (“AMYLIN”) and Mallinckrodt LLC (formerly known as Mallinckrodt Inc.) (“MALLINCKRODT”), as amended effective on and as of January 1, 2006, February 12, 2007, January 1, 2008, January 8, 2010 and February 14, 2011 (the “Supply Agreement”), is made and entered into between AMYLIN and MALLINCKRODT effective on and as of June 25, 2012 (except as and to the extent explicitly otherwise stated in this Sixth Amendment).
WHEREAS, the parties desire to amend the aforementioned Supply Agreement for the sixth time in certain respects,
NOW, THEREFORE, the parties hereto agree as follows:
		
	1.
	The following text shall be added to the beginning of Section 2.1:

“MALLINCKRODT agrees that, beginning in the ninth (9th) Contract Year (i.e., Calendar Year 2012) and during every other Contract Year thereafter, it will maintain manufacturing capacity sufficient to manufacture a maximum of [...***...] ([...***...]) [...***...] of Product per Contract Year for a maximum delivery of [...***...] ([...***...]) [...***...] to AMYLIN in each calendar quarter of such Contract Year.  In the event AMYLIN requires more than [...***...] ([...***...]) [...***...] of Product in any given Contract Year, the Parties agree to discuss in good faith an increase in the amount of Product to be supplied by MALLINCKRODT.”
		
	2.
	The following text shall be added to the ending of Section 2.2:

“All Product purchased on Purchase Orders submitted by AMYLIN pursuant to this Section 2.2 shall be ordered in increments of [...***...] ([...***...]) [...***...] per batch.  Within [...***...]               ([...***...]) [...***...] of June 25, 2012, AMYLIN shall submit a Purchase Order to MALLINCKRODT for [...***...] ([...***...]) [...***...] of Product (which shall be deemed to be delivered in the tenth Contract Year (i.e., calendar year 2013).”
		
	3.   
	Clause (iv) of Section 2.3 shall be amended by removing the word “and” from the end of such clause; clause (v) of Section 2.3 shall be amended by placing a comma after the first occurrence of the term “Contract Year” in such clause, deleting the words “and every subsequent Contract Year thereafter” and replacing them with the words “seventh, eighth and ninth Contract Years,” and removing the period at the end of the clause (v) and replacing it with a comma followed by the word “and”; a new clause (vi) 

 

***CONFIDENTIAL TREATMENT REQUESTED

shall be inserted at the end of Section 2.3, as herein amended, which shall read as follows:

“(vi) notwithstanding anything to the contrary in Clause (v) of this Section 2.3, during each of the tenth through twelfth Contract Years, at least [...***...] ([...***...]) [...***...] of Product per Contract Year.”

		
	4.
	Effective as of January 1, 2013, clauses (i) through (viii) of Section 2.4 shall be deleted in their entirety and replaced with the following clauses:

“(i) if in any given Contract Year the amount of Product ordered for delivery is [...***...] ([...***...]) [...***...] or less, the price per [...***...] will be $[...***...],

(ii)  if in any given Contract Year the amount of Product ordered for delivery is greater than or equal to [...***...] ([...***...]) [...***...] but less than [...***...] ([...***...]) [...***...], the price per [...***...] will be $[...***...],
 

(iii) if in any given Contract Year the amount of Product ordered for delivery is greater than or equal to [...***...] ([...***...]) grams but less than [...***...] ([...***...]) [...***...], the price per [...***...] will be $[...***...],

(iv) if in any given Contract Year the amount of Product ordered for delivery is greater than or equal to [...***...] ([...***...]) grams but less than [...***...] ([...***...]) [...***...], the price per [...***...] will be $[...***...],

(v) if in any given Contract Year the amount of Product ordered for delivery is greater than or equal to [...***...] ([...***...]) grams but less than [...***...] ([...***...]) [...***...], the price per [...***...] will be $[...***...],

(vi) if in any given Contract Year the amount of Product ordered for delivery is greater than or equal to [...***...] ([...***...]) [...***...] but less than [...***...] ([...***...]) [...***...], the price per [...***...] will be $[...***...], and

(vii) if in any given Contract Year the amount of Product ordered for delivery is greater than or equal to [...***...] ([...***...]) [...***...], the price per [...***...] will be $[...***...].”

***CONFIDENTIAL TREATMENT REQUESTED
    2

		
	5.
	In Section 7.1 of the Supply Agreement the phrase “nine (9) Contract Years” shall be replaced with the phrase “twelve (12) Contract Years”, thereby extending the initial term of the Supply Agreement by an additional seven (7) years.

6.    The text of Clause (iv) of Section 7.2 shall be deleted in its entirety and replaced with “[Reserved]”.

7.    In section 7.2(v) of the Supply Agreement “eighth (8th)” shall be replaced with “eleventh (11th)”, with the effect that the termination right set forth in Section 7.2(v) may not be exercised until after the elapse of the eleventh (11th) Contract Year.

Except as expressly amended herein, all of the other terms of the Supply Agreement shall remain unchanged and in full force and effect.

IN WITNESS WHEREOF, the parties hereto have executed this Sixth Amendment to Supply Agreement effective as of the day above written.

                    
Amylin Pharmaceuticals, Inc.

By:  /s/ Paul Marshall__________
Name:    Paul Marshall
Title:    Vice President, Operations
Date:    20 June 2012

                    

Mallinckrodt LLC

By:  /s/ Dawn Von Rohr_________
Name:  Dawn Von Rohr
Title:    VP & GM Global APIs
Date:    22 June 2012

***CONFIDENTIAL TREATMENT REQUESTED
    3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00206-of-00352.parquet"}]]